| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |